New antibiotics and new ways of using older drugs.
D000560:Amdinocillin / Q000627:therapeutic use; D000617:Aminoglycosides / Q000633:toxicity; D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001398:Aztreonam; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D015296:Ceftizoxime; D002444:Cefuroxime / Q000627:therapeutic use; D002648:Child; D002969:Clavulanic Acids / Q000627:therapeutic use; D003092:Colitis / Q000188:drug therapy; D004334:Drug Administration Schedule; D004357:Drug Synergism; D006801:Humans; D009428:Netilmicin / Q000627:therapeutic use; D010007:Osteochondritis / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012254:Ribavirin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014640:Vancomycin / Q000633:toxicity
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002969:Clavulanic Acids; D012254:Ribavirin; D009428:Netilmicin; D014640:Vancomycin; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D015296:Ceftizoxime; D001398:Aztreonam; D002439:Cefotaxime; D002444:Cefuroxime; D000560:Amdinocillin